IRIS

1.2 Recensione in rivista: [948] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 621 a 640 di 948
Titolo Data di pubblicazione Autore(i) File
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 1-gen-2022 Musacchio, L; Cicala, Cm; Salutari, V; Camarda, F; Carbone, Mv; Ghizzoni, V; Giudice, E; Nero, C; Perri, Mt; Ricci, C; Tronconi, F; Scambia, G; Lorusso, D
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? 1-gen-2020 Lorusso, D; Ray-Coquard, I; Oaknin, A; Banerjee, S
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM) 1-gen-2021 Gadducci, A; Aletti, Gd; Landoni, F; Lazzari, R; Mangili, G; Olivas, P; Pignata, S; Salutari, V; Sartori, E; Scambia, G; Zannoni, Gf; Sabbatini, R; Lorusso, D
Will68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update 1-gen-2018 Cuccurullo, V.; di Stasio, G. D.; Evangelista, L.; Ciarmiello, A.; Mansi, L.
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine 1-gen-2019 Carpanese, D.; Zorz, A.; Evangelista, L.; Salvarese, N.
Molecular imaging and immunotherapy 1-gen-2019 Evangelista, L.
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? 1-gen-2018 Evangelista, L.; Cuppari, L.
The new era of cancer immunotherapy: what can molecular imaging do to help? 1-gen-2017 Evangelista, L.; de Jong, M.; del Vecchio, S.; Cai, W.
Immunotherapy and 18F-FDG PET/CT: standardised procedures are needed 1-gen-2019 Evangelista, L.; De Rimini, M. L.; Bianchi, A.; Schillaci, O.
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 1-gen-2019 Alongi, P.; Laudicella, R.; Desideri, I.; Chiaravalloti, A.; Borghetti, P.; Quartuccio, N.; Fiore, M.; Evangelista, L.; Marino, L.; Caobelli, F.; Tuscano, C.; Mapelli, P.; Lancellotta, V.; Annunziata, S.; Ricci, M.; Ciurlia, E.; Fiorentino, A.
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2 1-gen-2019 Fiorentino, A.; Laudicella, R.; Ciurlia, E.; Annunziata, S.; Lancellotta, V.; Mapelli, P.; Tuscano, C.; Caobelli, F.; Evangelista, L.; Marino, L.; Quartuccio, N.; Fiore, M.; Borghetti, P.; Chiaravalloti, A.; Ricci, M.; Desideri, I.; Alongi, P.
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 1-gen-2020 Evangelista, Laura; Luca De Salvo, Gian; Zattoni, Fabio; Novara, Giacomo
Editorial comment 1-gen-2016 Evangelista, L.
Prostate cancer imaging: when the game gets tough, the hard one gets done! 1-gen-2018 Evangelista, L.; Sepulcri, M.; Maruzzo, M.
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer 1-gen-2019 Evangelista, L.; Cuppari, L.; Burei, M.; Zorz, A.; Caumo, F.
New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature [Figure presented] 1-gen-2016 Evangelista, L.; Briganti, A.; Fanti, S.; Joniau, S.; Reske, S.; Schiavina, R.; Stief, C.; Thalmann, G. N.; Picchio, M.
How can we optimize modem imaging techniques for breast cancer, with main reference to breast recurrence? 1-gen-2013 Evangelista, L.; Morris, P. G.; Mansi, L.
Re: Response Assessment of 223Ra Treatment: Should a Fluorocholine PET/CT Be Performed? 1-gen-2018 Evangelista, L.; Zorz, A.
The role of PET/CT in the evaluation of patients with urothelial cancer: a systematic review and meta-analysis 1-gen-2018 Cervino, A. R.; Cuppari, L.; Reccia, P.; Burei, M.; Saladini, G.; Evangelista, L.
Translational molecular imaging in exocrine pancreatic cancer 1-gen-2018 Cornelissen, B.; Knight, J. C.; Mukherjee, S.; Evangelista, L.; Xavier, C.; Caobelli, F.; Del Vecchio, S.; Rbah-Vidal, L.; Barbet, J.; de Jong, M.; van Leeuwen, F. W. B.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 621 a 640 di 948
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista948
Autore
  • REPICI, Alessandro67
  • HASSAN, CESARE48
  • EVANGELISTA, LAURA35
  • ARMUZZI, ALESSANDRO32
  • DANESE, Silvio29
  • ARIENTI, CHIARA27
  • SPINELLI, ANTONINO24
  • BOSSI, PAOLO22
  • CECCONI, Maurizio22
  • Rossi, Roberta Elisa22
Data di pubblicazione
  • 2020 - 2026767
  • 2010 - 2019160
  • 2000 - 200918
  • 1990 - 19992
  • 1985 - 19891
Rivista
  • JOURNAL OF CLINICAL MEDICINE37
  • CANCERS24
  • DIAGNOSTICS17
  • FRONTIERS IN IMMUNOLOGY17
  • INTERNATIONAL JOURNAL OF MOLECULA...17
  • CRITICAL REVIEWS IN ONCOLOGY HEMA...15
  • DIGESTIVE AND LIVER DISEASE13
  • FRONTIERS IN ONCOLOGY13
  • EUROPEAN JOURNAL OF PHYSICAL AND ...12
  • CANCER TREATMENT REVIEWS11
Keyword
  • Humans59
  • COVID-1918
  • inflammatory bowel disease18
  • Animals15
  • PET/CT12
  • Artificial intelligence8
  • cancer8
  • Crohn’s disease8
  • Neoplasms8
  • Prostate cancer8
Lingua
  • eng855
  • ita3
  • ger1
  • spa1
Accesso al fulltext
  • no fulltext927
  • reserved11
  • open9
  • partially open1